Chantal Rothschild

2.2k total citations · 1 hit paper
33 papers, 1.6k citations indexed

About

Chantal Rothschild is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Chantal Rothschild has authored 33 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 6 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Chantal Rothschild's work include Hemophilia Treatment and Research (18 papers), Platelet Disorders and Treatments (15 papers) and Cancer-related gene regulation (5 papers). Chantal Rothschild is often cited by papers focused on Hemophilia Treatment and Research (18 papers), Platelet Disorders and Treatments (15 papers) and Cancer-related gene regulation (5 papers). Chantal Rothschild collaborates with scholars based in France, United States and Belgium. Chantal Rothschild's co-authors include Jeanne M. Lusher, Frits R. Rosendaal, Louis M. Aledort, Jørgen Ingerslev, Gilbert White, Hérvè Chambost, Thierry Calvez, Jenny Goudemand, Christine Vinciguerra and Y. Laurian and has published in prestigious journals such as Blood, PLoS ONE and Journal of Clinical Microbiology.

In The Last Decade

Chantal Rothschild

32 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Definitions in Hemophilia

2001 601 citations Chantal Rothschild et al. Thrombosis and Haemostasis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chantal Rothschild France	15	1.3k	279	274	154	123	33	1.6k
Gerald Eder Austria	15	123 0.1×	139 0.5×	249 0.9×	251 1.6×	140 1.1×	39	1.4k
H.T.M. Cuypers Netherlands	19	240 0.2×	42 0.2×	294 1.1×	217 1.4×	85 0.7×	33	1.9k
J.‐R. Harle France	16	209 0.2×	44 0.2×	63 0.2×	303 2.0×	39 0.3×	53	1.1k
Ann E. Hohenhaus United States	20	235 0.2×	26 0.1×	185 0.7×	88 0.6×	65 0.5×	47	1.3k
K Groeneveld Netherlands	13	208 0.2×	108 0.4×	137 0.5×	110 0.7×	45 0.4×	22	1.1k
Philippe Bossi France	18	136 0.1×	65 0.2×	77 0.3×	435 2.8×	239 1.9×	44	992
Ippokratis Messaritakis Greece	23	131 0.1×	66 0.2×	375 1.4×	107 0.7×	13 0.1×	62	1.5k
Yuki Asano‐Mori Japan	18	417 0.3×	63 0.2×	61 0.2×	158 1.0×	14 0.1×	74	888
Souichi Shiratori Japan	15	301 0.2×	69 0.2×	137 0.5×	63 0.4×	12 0.1×	75	866
A. Graham Bird United Kingdom	19	137 0.1×	269 1.0×	213 0.8×	158 1.0×	108 0.9×	31	1.5k

Countries citing papers authored by Chantal Rothschild

Since Specialization

Citations

This map shows the geographic impact of Chantal Rothschild's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chantal Rothschild with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chantal Rothschild more than expected).

Fields of papers citing papers by Chantal Rothschild

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chantal Rothschild. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chantal Rothschild. The network helps show where Chantal Rothschild may publish in the future.

Co-authorship network of co-authors of Chantal Rothschild

This figure shows the co-authorship network connecting the top 25 collaborators of Chantal Rothschild. A scholar is included among the top collaborators of Chantal Rothschild based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chantal Rothschild. Chantal Rothschild is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

l′Escalopier, Nicolas de, Annie Harroche, Laurent Frenzel, et al.. (2017). Long-term results of ankle arthrodesis in children and adolescents with haemophilia. International Orthopaedics. 41(8). 1579–1584. 11 indexed citations

2.

Seck, Moussa, Blaise Félix Faye, Macoura Gadji, et al.. (2017). Bleeding risk assessment in hemophilia A carriers from Dakar, Senegal. Blood Coagulation & Fibrinolysis. 28(8). 642–645. 7 indexed citations

3.

Calvez, Thierry, Hérvè Chambost, Roseline d’Oiron, et al.. (2017). Analyses of the FranceCoag cohort support differences in immunogenicity among one plasma-derived and two recombinant factor VIII brands in boys with severe hemophilia A. Haematologica. 103(1). 179–189. 40 indexed citations

4.

Kauskot, Alexandre, Sonia Poirault‐Chassac, Frédéric Adam, et al.. (2016). LIM kinase/cofilin dysregulation promotes macrothrombocytopenia in severe von Willebrand disease-type 2B. JCI Insight. 1(16). e88643–e88643. 19 indexed citations

5.

Meunier, Sandrine, Roseline d’Oiron, Hérvè Chambost, et al.. (2016). Choice of factor VIII/IX regimen in adolescents and young adults with severe or moderately severe haemophilia. A French national observational study (ORTHem 15-25). Thrombosis Research. 151. 17–22. 3 indexed citations

6.

Berrou, Eliane, Alexandre Kauskot, Frédéric Adam, et al.. (2015). Apoptotic Platelet Events Are Not Observed in Severe von Willebrand Disease-Type 2B Mutation p.V1316M. PLoS ONE. 10(12). e0143896–e0143896. 3 indexed citations

7.

Calvez, Thierry, Hérvè Chambost, Chantal Rothschild, et al.. (2015). EQOFIX: a combined economic and quality‐of‐life study of hemophilia B treatments in France. Transfusion. 55(7). 1787–1797. 13 indexed citations

8.

Calvez, Thierry, Hérvè Chambost, Ségolène Claeyssens‐Donadel, et al.. (2014). Recombinant factor VIII products and inhibitor development in previously untreated boys with severe hemophilia A. Blood. 124(23). 3398–3408. 108 indexed citations

9.

Rothschild, Chantal. (2013). Equine Piroplasmosis. Journal of Equine Veterinary Science. 33(7). 497–508. 96 indexed citations

10.

Rothschild, Chantal, Hérvè Chambost, Édouard Tuaillon, et al.. (2009). FVIII Specific Memory B Lymphocytes in Hemophilia A with Inhibitors Treated by Immune Tolerance Induction.. Blood. 114(22). 3162–3162. 1 indexed citations

11.

Jandrot‐Perrus, Martine, Bénédicte Dumont, Dominique Lasne, et al.. (2008). Absent Collagen-Induced Platelet Activation in a Patient Double Heterozygous for Two GPVI Mutations. Blood. 112(11). 88–88. 8 indexed citations

12.

Rothschild, Chantal, et al.. (2008). Dramatic Efficacy of Sequential Bypassing Agent Treatment for a Life-Threatening Bleeding in An Infant with Severe Hemophilia and Inhibitor. Blood. 112(11). 4501–4501. 1 indexed citations

13.

Gill, Joan Cox, Chantal Rothschild, Marilyn J. Manco‐Johnson, et al.. (2005). Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A. Thrombosis and Haemostasis. 93(3). 457–467. 79 indexed citations

14.

Rothschild, Chantal, Melissa T. Hines, Babetta A. Breuhaus, John Gay, & Debra C. Sellon. (2004). Effects of Trimethoprim-Sulfadiazine on Thyroid Function of Horses. Journal of Veterinary Internal Medicine. 18(3). 370–370. 13 indexed citations

15.

Rothschild, Chantal, Melissa T. Hines, Babetta A. Breuhaus, John Gay, & Debra C. Sellon. (2004). Effects of Trimethoprim-Sulfadiazine on Thyroid Function of Horses. Journal of Veterinary Internal Medicine. 18(3). 370–373. 12 indexed citations

16.

Viard, Jean‐Paul, Marianne Burgard, Jean‐Baptiste Hubert, et al.. (2004). Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level. AIDS. 18(1). 45–49. 133 indexed citations

17.

Rothschild, Chantal, et al.. (2004). Effects of trimethoprim–sulfadiazine on tear production and the fluctuations of Schirmer tear test values in horses. Veterinary Ophthalmology. 7(6). 385–390. 20 indexed citations

18.

Lasne, Dominique, et al.. (2003). Extracorporeal adsorption of anti-Factor VIII allo-antibodies on randomly functionalized polystyrene resins. Thrombosis and Haemostasis. 91(2). 259–266. 11 indexed citations

19.

Obert, Bernadette, et al.. (2000). Mapping and Functional Studies of Two Alloantibodies Developed in Patients with Type 3 von Willebrand Disease. Thrombosis and Haemostasis. 83(2). 274–281. 15 indexed citations

20.

Fressinaud, Édith, Augusto B. Federici, Giancarlo Castaman, et al.. (1994). The role of platelet von Willebrand factor in platelet adhesion and thrombus formation: a study of 34 patients with various subtypes of type I von Willebrand disease. British Journal of Haematology. 86(2). 327–332. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact